HR 421

Title: Allowing Greater Access to Safe and Effective Contraception Act
Author: Rep. Mia Love (REP-UT)

...This bill requires the Food and Drug Administration (FDA) to prioritize review of supplemental drug applications (applications to modify the approved use of a drug) for contraceptive drugs intended for routine use that would be available to individuals aged 18 and older without a prescription. The FDA must waive user fees for such supplemental drug applications. Any drug that is eligible for this priority review must be a prescription drug for individuals under age 18.</p> This bill repeals provisions of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 to allow health savings accounts and health flexible spending accounts (HFSAs) to be used to pay for medicine without a prescription and to remove the limit on salary reduction ...

Introduced in House 01/10/2017
Introduced in House 01/10/2017
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. 01/10/2017
Referred to House Ways and Means 01/10/2017
Referred to House Energy and Commerce 01/10/2017
Referred to the Subcommittee on Health. 01/25/2017
Referred to the Subcommittee on Health. 01/26/2017

Bill Text
08/16/2017 - HR 421 (Introduced+in+House)
01/10/2017 - HR 421 (Introduced+in+House)
01/10/2017 - HR 421 (Introduced+in+House)

Add To Favorites In PHR

Author Details

    Rep. Mia Love (R-UT)
    () - U.S. Representative

    Visit their Website

    Contact Tips

    Capital Address:
    217 Cannon House Office Building

    Washington, DC 20515-4404
    Phone: (202) 225-3011

    District Address:
    9067 South 1300 West, Suite 101

    West Jordan, UT 84088
    Phone: (801) 996-8729
    Fax: (801) 987-8631


Driving Walking/Biking Public Transit  Get Directions